DiaMedica Therapeutics (DMAC) Interest Coverage Ratio Growth (1y) (2025 - 2026)
Powered by 
Analysis
DiaMedica Therapeutics (DMAC) Interest Coverage Ratio Growth (1y) (2025 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.55 Bn | 192.56 Bn | 7.24 Bn | 36.43% |
| 2 | Gilead Sciences | 180.15 Bn | 176.98 Bn | 6.22 Bn | -532.04% |
| 3 | Vertex Pharmaceuticals | 131.59 Bn | 123.73 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.98 Bn | 73.98 Bn | 3.93 Bn | -60.78% |
| 5 | Argenx Se | 60.33 Bn | 55.14 Bn | 1.37 Bn | 176.09% |
| 6 | Moderna | 53.75 Bn | 48.61 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.06 Bn | 29.76 Bn | 992.69 Mn | 1,170.12% |
| 8 | Biogen | 31.95 Bn | 30.67 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.25 Bn | 29.25 Bn | 1.16 Mn | - |
| 10 | DiaMedica Therapeutics | 341.69 Mn | 341.69 Mn | - | - |